FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
VinFast, the Vietnamese electric-vehicle maker, and Arm, a British chip designer, are caught in a weird limbo thanks to their decisions on where to list their shares. Source link
Find insights on next generation treatments for Covid-19, Medtronic’s high blood pressure treatment, and more in the latest Market Talks covering the Health Care sector. Source link
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link